Literature DB >> 16495816

Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen.

Laurence Kessler, Catalina Lucescu, Michel Pinget, Marie Noelle Charton, Veronique Mutschler, Philippe Wolf, Thierry Berney, Pierre Yves Benhamou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495816     DOI: 10.1097/01.tp.0000188946.82239.68

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Bilateral Inflammatory Optic Neuropathy Related to Graft versus Host Disease Following Allogeneic Bone Marrow Transplantation for Hodgkin Disease.

Authors:  I Moesen; D P Kidd
Journal:  Neuroophthalmology       Date:  2014-07-22

2.  Tacrolimus Optic Neuropathy Mimicking Papilledema.

Authors:  Isra M Hussein; Jonathan A Micieli
Journal:  Case Rep Ophthalmol       Date:  2022-05-10

3.  A case of reversible toxic optic neuropathy from tacrolimus (FK506).

Authors:  Kimberly K Gokoffski; Vivek R Patel
Journal:  Am J Ophthalmol Case Rep       Date:  2020-09-16

4.  Electroretinographic findings in transplant chorioretinopathy.

Authors:  Brian T Chan-Kai; Steven Yeh; Richard G Weleber; Peter J Francis; Grazyna Adamus; S Robert Witherspoon; Andreas K Lauer
Journal:  Clin Ophthalmol       Date:  2010-07-30

5.  Tacrolimus-induced unilateral ischaemic optic neuropathy in a non-transplant patient.

Authors:  Monika Gupta; Reema Bansal; Nikhil Beke; Amod Gupta
Journal:  BMJ Case Rep       Date:  2012-08-21

6.  Maculopathy associated with tacrolimus (FK 506).

Authors:  Taehyuk Koh; Seung-Hee Baek; Jung Il Han; Ungsoo Samuel Kim
Journal:  Korean J Ophthalmol       Date:  2011-01-17

7.  The Effect of Maintenance Treatment with Twice-Daily or Prolonged Once-Daily Tacrolimus Formulation on Visual Evoked Potentials in Stable Kidney Transplant Recipients.

Authors:  Aureliusz Kolonko; Małgorzata Jurys; Sebastian Sirek; Tomasz Dwulit; Dorota Pojda-Wilczek; Andrzej Więcek
Journal:  J Clin Med       Date:  2020-06-11       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.